Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Tetrahedron Letters|April 15, 2020
Facile route for <i>N</i> <sub>1</sub>-aryl benzotriazoles from diazoamino arynes via CuI-mediated intramolecular N-arylationRaju R Kale, Virendra Prasad, H A Hussain, et al.Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology|November 24, 2016
<i>Toxocara vitulorum</i> in a suckling calf: a case studyRayies Ahmed, Z A Wani, I M Allaie, et al.Journal of the National Cancer Institute|February 13, 2009
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trialMichael E Ray, Kyounghwa Bae, Maha H A Hussain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology GroupMichael K Gibson, Yi Li, Barbara Murphy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trialThomas W Flaig, Catherine M Tangen, Maha H A Hussain, et al.Prostate Cancer and Prostatic Diseases|January 9, 2021
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusionsZachary R Chalmers, Michael C Burns, Ericka M Ebot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancerEthan M Basch, Mark R Somerfield, Tomasz M Beer, et al.JAMA Oncology|March 31, 2017
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone InductionThomas W Flaig, Melissa Plets, Maha H A Hussain, et al.The Journal of Urology|April 18, 2009
A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219)Ralph W deVere White, Primo N Lara, Bryan Goldman, et al.The Prostate|September 5, 2002
SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group studyCatherine E Klein, Catherine M Tangen, Thomas J Braun, et al.Pageof 5